Simple Summary Hyperthermic intrathoracic chemotherapy (HITHOC) is an intraoperative
and topical administration of chemotherapeutic drugs with simultaneous warming of the …

Background Optimal treatment for thymoma with pleural dissemination (TPD) remains
unclear. Extended radical resection is the cornerstone for local treatment but the need for …

Objectives Pleural metastasis has extremely poor prognosis. Resection of pleural implants
with infusion of intrathoracic hyperthermic chemotherapy may offer a survival advantage in …

12Department of Radiation Oncology, VCU Health, Richmond, VA 13Division of Thoracic
Surgery, Keck School of Medicine of the University of Southern California, Los Angeles, CA …

Methods Diagnostic methods must be chosen accurately to avoid unnecessary surgical
resections, to define the best strategy of care, and to plan the surgical strategy. Therefore …

The safety and efficacy of hyperthermic intrathoracic chemotherapy (HITHOC) as an adjunct
to cytoreductive surgery (CRS) in pleural malignancies has been well demonstrated. This is …

Simple Summary Stage IVa thymomas are rare entities in thoracic oncology without a
standard of care. Evidence-based guidelines for the management of located pleural …

According to a modern view, cancer no longer follows a purely mechanistic model. Rather, a
tumor is conceived as a more complex structure, composed of cancer cells, the activities of …

This case report details the application and outcomes of a novel therapeutic approach
involving hyperthermic intraperitoneal chemotherapy (HIPEC) and hyperthermic …

Li‐Fraumeni syndrome (LFS) is a cancer predisposition syndrome associated with a high,
lifetime risk of a broad spectrum of cancers caused by pathogenic germline TP53 mutations …